Extensive aortic thromboembolism due to acquired hypercoagulable state: An autopsy case report

Archives of Pathology and Laboratory Medicine

Volumn 129, Issue 2, 2005, Pages 247-250

  Zhang, Ling ^a   Hollensead, Sandra ^a   Parker Jr , Joseph C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; AORTA THROMBOSIS; AUTOPSY; CASE REPORT; CLINICAL FEATURE; COLON RESECTION; CONFERENCE PAPER; DEATH; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERCOAGULABILITY; JEJUNOSTOMY;

AORTA, THORACIC; AUTOPSY; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 13444287978     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Sakakibara Y, Sasaki A, Nakata H, Osaka M, Hiramatsu Y, Mitsui T. Acute aortic thrombosis after intra-aortic balloon pumping. Jpn J Thorac Cardiovasc Surg. 2000;48:123-152.
2. Vaideeswar P, Deshpande JR. Non-atherosclerotic aorto-arterial thrombosis: a study of 30 cases at autopsy. J Postgrad Med. 2001;47:8-14.
3. Bhagia ST, Livesay JJ, Reul GJ, Cooley DA. Hypercoagulable state leading to paraplegia in a middle-aged man. Tex Heart Inst J. 2002;29:30-32.
4. Seror O, Fain O, Dordea M, Ghenassia C, Coderc E, Sellier N. Aortitis with antiphospholipid antibodies: CT and MR findings. Eur Radiol. 1998;8:1373-1375.
5. Van Cotet EM, Laposata M, Prins MH. Laboratory evaluation of hypercoagulability with venous or arterial thrombosis: venous thromboembolism, myocardial infarction, stroke, and other conditions. Arch Pathol Lab Med. 2002;126:1281-1291.
6. Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. 2003;107:398-404.
7. Bowles LK, Cooper JA, Howarth DJ, Miller GJ, MacCallum P. Association of haemostatic variables with body mass index: a community-base study. Blood Coagul Fibrinolysis. 2003;14:569-573.
8. Press RD, Bauer KA, Kujovich JL, Heit JA. Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med. 2002;126:1304-1318.
9. McGlennen RC, Key NS. Clinical and laboratory management of the prothrombin G20210A mutation. Arch Pathol Lab Med. 2002;126:1319-1325.
10. Hanson NQ, Aras O, Yang F, Tsai MY. C667T and A1298C polymorphisms of the methylenetetra-hydrofolate reductase gene: incidence and effect of combined genotypes on plasma fast and post-thionine load homocysteine in vascular disease. Clin Chem. 2001;47:661-666.
11. Key NS, McGlennen RC. Hyperhomocyst(e)inemia and thrombophilia. Arch Pathol Lab Med. 2002;126:1367-1375.
12. Galli M, Barbui T. Antiphospholipid antibodies and thrombosis: strength of association. Hematol J. 2003;4:180-186.
13. Bick RL. Antiphospholipid thrombosis syndrome. Hematol Oncol Clin North Am. 2003;17:115-147.
14. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003;101:1827-1832.
15. De Lorenzo F, Xiao H, Scully M, Kadziola Z, Kakkar VV. Pre-thrombotic state and impaired fibronolytic potential in coronary heart disease patients with left ventricular dysfunction. Blood Coagul Fibrinolysis. 2003;14:67-75.